Ligand validation:4RVY

SQD: 1,2-DI-O-ACYL-3-O-[6-DEOXY-6-SULFO-ALPHA-D-GLUCOPYRANOSYL]-SN-GLYCEROL

SQD is a Ligand Of Interest in 4RVY designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4RVY_SQD_l_102	10%	37%	0.317	0.823	1.08	1.44	4	9	0	0	100%	1
4RVY_SQD_l_101	10%	40%	0.323	0.825	1.04	1.36	4	8	0	0	100%	1
4RVY_SQD_B_601	4%	43%	0.35	0.727	1.04	1.22	3	6	0	0	100%	1
4RVY_SQD_b_621	4%	37%	0.404	0.769	1.08	1.44	4	9	0	0	100%	1
4RVY_SQD_L_101	3%	40%	0.412	0.767	1.04	1.36	4	8	0	0	100%	1
4RVY_SQD_b_601	2%	43%	0.489	0.727	1.05	1.22	3	6	0	0	100%	1
4RVY_SQD_a_609	1%	37%	0.527	0.637	0.99	1.53	3	11	0	0	100%	1
4RVY_SQD_A_609	0%	37%	0.632	0.654	0.99	1.53	3	11	0	0	100%	1
4RVY_SQD_d_411	0%	35%	0.91	0.61	1.21	1.46	3	7	0	0	80%	0.7963
4RVY_SQD_D_411	0%	35%	1.268	0.661	1.21	1.45	4	7	0	0	80%	0.7963
5V2C_SQD_a_413	94%	24%	0.075	0.976	1.12	2.14	4	12	0	0	100%	1
6DHE_SQD_A_412	77%	23%	0.113	0.961	1.05	2.27	5	14	0	0	96%	0.963
8IRC_SQD_a_411	77%	32%	0.119	0.96	0.96	1.83	3	13	0	0	100%	1
8IR5_SQD_a_411	75%	33%	0.123	0.958	0.95	1.77	3	13	0	0	100%	1
8IRF_SQD_a_410	75%	32%	0.125	0.96	0.96	1.83	3	13	0	0	100%	0.49
8IR8_SQD_a_409	75%	33%	0.126	0.96	0.95	1.77	3	13	0	0	100%	0.4

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.